Unprotected left main stenting with a second-generation drug-eluting stent: One-year outcomes of the LEMAX Pilot study

EuroIntervention

Volumn 7, Issue 6, 2011, Pages 689-696

  Salvatella, Neus ^a   Morice, Marie Claude ^a   Darremont, Olivier ^b   Tafflet, Muriel ^c,d   Garot, Philippe ^e   Leymarie, Jean Louis ^f   Chevalier, Bernard ^a   Lefev̀re, Thierry ^a   Louvard, Yves ^a   Boudou, Nicolas ^f   Dumonteil, Nicolas ^f   Carrie, Didier ^f  

^a INSTITUT HOSPITALIER JACQUES CARTIER   (France)

^b CLINIQUE SAINT AUGUSTIN   (France)

^c PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e hopital prive Claude Galien   (France)

^f CHU RANGUEIL   (France)

Author keywords

Drug eluting stent; everolimus eluting stent; Left main; Percutaneous coronary intervention

Indexed keywords

EVEROLIMUS;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; CEREBROVASCULAR DISEASE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; DRUG ELUTING STENT; EVEROLIMUS ELUTING STENT; FEMALE; FOLLOW UP; FRANCE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PILOT STUDY; Q WAVE; RESTENOSIS; REVASCULARIZATION; SAFETY; STENT THROMBOSIS; STROKE; UNPROTECTED LEFT MAIN CORONARY ARTERY DISEASE;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON, CORONARY; CARDIOVASCULAR AGENTS; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; CORONARY STENOSIS; DRUG-ELUTING STENTS; FEMALE; HOSPITAL MORTALITY; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PILOT PROJECTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SIROLIMUS; STROKE; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 80155171783     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV7I6A111     Document Type: Article

References (30)

1. Patel MR, Dehmer GJ, Hirshfeld JW, Smith PK, Spertus JA. ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: A Report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol. 2009;53:530-553.
2. Vaquerizo B, Lefèvre T, Darremont O, Silvestri M, Louvard Y, Leymarie JL, Garot P, Routledge H, de Marco F, Unterseeh T, Zwahlen M, Morice MC. Unprotected Left Main Stenting in the Real World. Two-Year Outcomes of the French Left Main Taxus Registry. Circulation. 2009;119:1383-1389.
3. Chieffo A, Magni V, Latib A, Masiano F, Ielasi A, Montorfano M, Carlino M, Godino C, Ferraro M, Calori G, Alfieri O, Colombo A. 5-Year Outcomes Following Percutaneous Coronary Intervention With Drug-Eluting Stent Implantation Versus Coronary Bypass Graft for Unprotected Left Main Coronary Artery Lesions: The Milan Experience. J Am Coll Cardiol Intv. 2010;3:595-560.
4. Park SJ, Kim YH, Park DW, Yun SC, Ahn JM, Song HG, Lee JY, Kim WJ, Kang SJ, Lee SW, Lee CW, Park SW, Chung CH, Lee JW, Lim DS, Rha SW, Lee SG, Gwon HC, Kim HS, Chae IH, Jang Y, Jeong MH, Tahk SJ, Seung KB. Randomized Trial of Stents versus Bypass Surgery for Left Main Coronary Artery Disease. N Engl J Med. 2011;364:1718-1727.
5. Mehilli J, Kastrati A, Byrne RA, Bruskina O, Iijima R, Schulz S, Pache J, Seyfarth M, Massberg S, Lagwitz KL, Dirschinger J, Schömig A. Paclitaxel- versus Sirolimus-Eluting Stents for Unprotected Left Main Coronary Artery Disease. J Am Coll Cardiol. 2009;53:1760-1768.
6. Park DW, Seung KB, Kim YH, Lee JY, Kim WJ, Kang SJ, Lee SW, Lee CW, Park SW, Yun SC, Seong IW, Park HS, Ahn T,Chae IH, Tahk SJ, Chung WS, Park SJ. Long-Term Safety and Efficacy of Stenting Versus Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Artery Disease: 5-Year Results From the MAIN-COMPARE (Revascularization for Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization) Registry. J Am Coll Cardiol. 2010;56:117-124.
7. Morice MC, Serruys PW, Kappetein P, Feldman TE, Ståhle E, Colombo A, Mack MJ, Holmes DR, Torracca L, van Es GA, Leadley K, Dawkins KD, Mohr F. Outcomes in Patients With De Novo Left Main Disease Treated With Either Percutaneous Coronary Intervention Using Paclitaxel-Eluting Stents or Coronary Artery Bypass Graft Treatment in the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgey (SYNTAX) Trial. Circulation. 2010;121:2645-2653.
8. Buszman PE, Kiesz SR, Bochenek A, Peszek-Przybyla E, Szkrobka I, Debinksi M, Bialkowska B. Dudek D, Gruszka A, Zurakowski A, Milewski K, Wilczynski M, Rzeszutko L, Buszman P, Szymszal J, Martin JL, Tendera M Acute and Late Outcomes of Unprotected Left Main Stenting in Comparison With Surgical Revascularization. J Am Coll Cardiol. 2008;51:538-545. (Pubitemid 351146684)
9. Boudriot E, Thiele H, Walther T, Liebetrau C, Boeckstegers P, Pohl T, Reichart B, Mudra H, Beier F, Gansera B, Neumann FJ, Gick M, Zietak T, Desch S, Schuler G, Mohr FW. Randomized Comparison of Percutaneous Coronary Intervention With Sirolimus-Eluting Stents Versus Coronary Artery Bypass Grafting in Unprotected Left Main Stem Stenosis. J Am Coll Cardiol. 2011;57:538-545.
10. Kushner FG, Hand M, Smith SC, King SB, Anderson JL, Antman EM, Bailey SR, Bates ER, Blankenship JC, Casey DE, Green LA, Hochman JS, Jacobs AK, Krumholz HM, Morrison DA, Ornato JP, Pearle DL, Peterson ED, Sloan MS, Whitlow PL, Williams DO. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/ AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): a report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2009;54:2205-2241.
11. Wijns W, Kolh P, Danchin M, Di Mario C, Falk V, Folliguet T, Garg S, Huber K, James S, Knuuti J, Lopez-Sendon J, Marco J, Menicanti L, Ostojic M, Piepoli MF, Pirlet C, Pomar JL, Reifart N, Ribichini FL, Schalij MJ, Sergeant P, Serruys PW, Silber S, Sousa Uva M, Taggart D.The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2010;31:2501-2555.
12. Kedhi E, Joesoef KS, McFadden E, Wassing J, van Nieghem C, Goedfart, Smits PC. Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial. Lancet. 2010;375:201-209.
13. Stone GW, Rizvi AR, Newman W, Mastali K, Wang JC, Caputo R, Doostzadeh J, Cao S, Simonton CA, Sudhir K, Lansky AJ, Cutlip DE, Kereiakes DJ. Everolimus-Eluting versus Paclitaxel-Eluting Stents in Coronary Artery Disease. N Engl J Med. 2010;362:1663-1674.
14. Finet G, Gilard M, Perrenot B, Rioufol G, Motreff P, Gavit L, Prost R. Fractal geometry of arterial coronary bifurcations: a quantitative coronary angiography and intravascular ultrasound analysis. EuroIntervention. 2007;3:490-498.
15. Hildick-Smith D, Lassen JF, Albiero R, Lefèvre T, Darremont O, Pan M, Ferenc M, Stankovic G, Louvard Y. Consensus from the 5th European Bifurcation Club Meeting. EuroIntervention. 2010;6: 34-38.
16. Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, Dawkins K, van den Brand M, Van Dyke N, Russell ME, Mohr FW, Serruys PW. The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention. 2005;1:219-227.
17. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115:2344-2351. (Pubitemid 46685903)
18. Valgimigli M, Malagutti P, Aoki J, Garcia-Garcia HM, Rodriguez Granillo GA, van Mieghem CA, Ligthart JM, Ong AT, Sianos G, Regar E, Van Domburg RT, De Feyter P, de Jaegere P, Serruys PW. Sirolimus-eluting versus paclitaxel-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: a combined RESEARCH and T-SEARCH long-term analysis. J Am Coll Cardiol. 2006;47:507-514. (Pubitemid 43170837)
19. Lee JY, Park QW, Yun SY, Lee SW, Kim YH, Lee CW, Hong MK, Park SW, Park SJ. Long-Term Clinical Outcomes of Sirolimus- Versus Paclitaxel-Eluting Stents for Patients With Unprotected Left Main Coronay Artery Disease. Analysis of the MAIN-COMPARE (Revascularization for Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization) Registry. J Am Coll Cardiol. 2009;54:853-859.
20. Chieffo A, Park SJ, Meliga E, Sheiban I, Lee MS, Latib A, Kim YH, Valgimigli M, Sillano D, Magni V, Biondi-Zoccai G, Montorfano M, Airoldi F, Rogacka R, Carlino M, Michev I, Lee CW, Hong MK, Park SW, Moretti C, Bonizzoni E, Sangiorgi GM, Tobis J, Serruys PW, Colombo A. Late and very late stent thrombosis following drugeluting stent implantation in unprotected left main coronary artery: a multicentre registry. Eur Heart J. 2008;29:2108-2115.
21. Palmerini T, Sangiorgi D, Marzocchi A, Tamburino C, Sheiban I, Margheri M, Vecchi G, Sangiorgi G, Ruffini M, Bartorelli AL, Briguori C, Vignali L, Di Pede F, Ramondo A, Inglese L, De Carlo M, Bolognese L, Benassi A, Palmieri C, Filippone V, Barlocco F, Lauria G, De Servi S. Ostial and midshaft lesions vs. Bifurcation lesions in 1111 patients with unprotected left main coronary artery stenosis treated with drug-eluting stents: results of the survey from the Italian Society of Invasive Cardiology. Eur Heart J. 2009;30: 2087-2094.
22. Kim YH, Park SW, Hong MK, Park DW, Park KM, Lee BK, Song JM, Han KH, Lee CW, Kang DH, Song JK, Kim JJ, Park SJ. Comparison of simple and complex stenting techniques in the treatment of unprotected left main coronary artery bifurcation stenosis. Am J Cardiol. 2006;97:1597-1601. (Pubitemid 43737032)
23. Chieffo A, Stankovic G, Bonizzoni E, Tsagalou A, Iakovou I, Montorfano M, Airoldi F, Michev I, Sangiorgi MG, Carlino M, Vitrella G, Colombo A. Early and Mid-Term Results of Drug- Eluting Stent Implantation in Unprotected Left Main. Circulation. 2005;111:791-795. (Pubitemid 40250640)
24. Price MJ, Cristea E, Sawhney N, Kao JA, Moses JW, Leon MB, Costa RA, Lansky AJ, Terstein PS. Serial Angiographic Follow-Up of Sirolimus-Eluting Stents for Unprotected Left Main Coronay Artery Revascularization. J Am Coll Cardiol. 2006;47:871-877. (Pubitemid 43243114)
25. Van Mieghem CAG, Cademartiri F, Mollet NR, Malagutti P, Valgimigli M, Meijboom WB, Pugliese F, McFadden EP, Ligthart J, Runza G, Bruining N, Smits PC, Regar E, van der Giessen WJ, Sianos G, van Domburg R, de Jaegere P, Krestin GP, Serruys PW, de Feyter PJ. Multislice Spiral Computed Tomography for the Evaluation of Stent Patency After Left Main Coronary Artery Stenting: A Comparison With Conventional Coronary Angiography and Intravascular Ultrasound. Circulation. 2006;114;645-653. (Pubitemid 44252306)
26. Nashef SAM, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg.1999;16:9-13. (Pubitemid 29336425)
27. Capodanno D, Di Salv ME, Cincotta G, Miano M, Tamburino C, Tamburino C. Usefulness of the SYNTAX Score for Predicting Clinical Outcome After Percutaneous Coronary Intervention of Unprotected Left Main Coronary Artery Disease. Circ Cardiovasc Interv. 2009;2:302-308.
28. Kim YH, Park DW, Kim WJ, Lee JY, Yun SC, Kang SJ, Lee SW, Lee CH, Park SW, Park SJ. Validation of SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) Score for Prediction of Outcomes After Unprotected Left Main Coronary Revascularization. J Am Coll Cardiol Intv. 2010;3:612-623.
29. Kim YH, Ahn JM, Park DW, Lee BK, Lee CW, Hong MK, Kim JJ, Park SW. EuroSCORE as a Predictor of Death and Myocardial Infarction After Unprotected Left Main Coronary Stenting. Am J Cardiol. 2006;98:1567-1570. (Pubitemid 44827961)
30. Capodanno D, Miano M, Cincotta G, Caggegi A, Ruperto C, Bucalo R, Sanfilippo A, Capranzano P, Tamburino C. EuroSCORE refines the predictive ability of SYNTAX score in patients undergoing left main percutaneous coronary intervention. Am Heart J. 2010;159:103-109.